ES2054325T3 - Nuevos estereoisomeros. - Google Patents

Nuevos estereoisomeros.

Info

Publication number
ES2054325T3
ES2054325T3 ES90850243T ES90850243T ES2054325T3 ES 2054325 T3 ES2054325 T3 ES 2054325T3 ES 90850243 T ES90850243 T ES 90850243T ES 90850243 T ES90850243 T ES 90850243T ES 2054325 T3 ES2054325 T3 ES 2054325T3
Authority
ES
Spain
Prior art keywords
propil
etil
amino
propilsulfinil
hidroxipropoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90850243T
Other languages
English (en)
Inventor
Knut Olle Seved Almgren
Kjell Hjalmar Andersson
Bernt Goran Duke Duker
Bo Robert Lamm
Gert Christer Strandlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Application granted granted Critical
Publication of ES2054325T3 publication Critical patent/ES2054325T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Laminated Bodies (AREA)
  • Stereo-Broadcasting Methods (AREA)

Abstract

4-[3-[ETIL[3-(R)-(PROPILSULFINIL)PROPIL]AMINO]-2(R)-HIDROXIPROPOXI]BENZONITRILO 4-[3-[ETIL[3-((S)-(PROPILSULFIMIL)PROPIL]AMINO]-2(R)-HIDROXIPROPOXI]BENZONITRILO 4-[3-[ETIL[3-((R)-(PROPILSULFINIL) PROPIL]AMINO]-2(S)-HIDROXIPROPOXI]BENZONITRILO 4-[3-[ETIL[3-[((S)-(PROPILSULFINIL)PROPIL]AMINO]-2-(S)-HIDROXIPROPOXI]BENXONITRILO Y SALES ACEPTABLES FARMACEUTICAMENTE DE ELLOS. SE DESCRIBE UN PROCESO PARA SU PREPARACION Y EL USO DE ESTOS COMPONENETES EN LA FABRICACION DE MEDICAMENTOS DE ACION CONTRA LA MITMIA CARDIACA.
ES90850243T 1989-06-20 1990-06-19 Nuevos estereoisomeros. Expired - Lifetime ES2054325T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902237A SE8902237D0 (sv) 1989-06-20 1989-06-20 Novel stereoisomers

Publications (1)

Publication Number Publication Date
ES2054325T3 true ES2054325T3 (es) 1994-08-01

Family

ID=20376342

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90850243T Expired - Lifetime ES2054325T3 (es) 1989-06-20 1990-06-19 Nuevos estereoisomeros.

Country Status (31)

Country Link
US (1) US5055490A (es)
EP (1) EP0404748B1 (es)
JP (1) JPH04506076A (es)
KR (1) KR920702676A (es)
CN (1) CN1048213A (es)
AT (1) ATE88698T1 (es)
AU (1) AU641665B2 (es)
BG (1) BG60164A3 (es)
CA (1) CA2058941A1 (es)
CZ (1) CZ278988B6 (es)
DE (1) DE69001461T2 (es)
DK (1) DK0404748T3 (es)
ES (1) ES2054325T3 (es)
FI (1) FI915937A0 (es)
HR (1) HRP920625A2 (es)
HU (1) HU211024B (es)
IE (1) IE902161A1 (es)
IL (1) IL94677A0 (es)
LT (1) LTIP1727A (es)
LV (1) LV10248A (es)
MX (1) MX174254B (es)
NO (1) NO914929L (es)
NZ (1) NZ234023A (es)
PH (1) PH27009A (es)
PL (1) PL163988B1 (es)
PT (1) PT94417A (es)
RU (1) RU2032663C1 (es)
SE (1) SE8902237D0 (es)
WO (1) WO1990015794A1 (es)
YU (1) YU120690A (es)
ZA (1) ZA904411B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
SE8902236D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel polystyrenesulfonate
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
DE19546159A1 (de) 1995-12-11 1997-06-12 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topisch wirksamen Therapie postoperativer und posttraumatischer Wundschmerzen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457876A (en) * 1972-12-15 1976-12-08 Ici Ltd Alkanolamine derivatives device for use in
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents

Also Published As

Publication number Publication date
EP0404748A1 (en) 1990-12-27
AU5851490A (en) 1991-01-08
CZ278988B6 (en) 1994-11-16
CN1048213A (zh) 1991-01-02
RU2032663C1 (ru) 1995-04-10
PH27009A (en) 1993-02-01
HU905353D0 (en) 1992-03-30
DE69001461T2 (de) 1993-08-26
WO1990015794A1 (en) 1990-12-27
YU120690A (sh) 1992-07-20
US5055490A (en) 1991-10-08
NO914929D0 (no) 1991-12-13
NO914929L (no) 1991-12-13
ZA904411B (en) 1991-02-27
KR920702676A (ko) 1992-10-06
MX21202A (es) 1993-09-01
NZ234023A (en) 1992-03-26
CA2058941A1 (en) 1990-12-21
AU641665B2 (en) 1993-09-30
LTIP1727A (en) 1995-07-25
IE902161L (en) 1990-12-20
BG60164A3 (en) 1993-11-15
LV10248A (lv) 1994-10-20
ATE88698T1 (de) 1993-05-15
MX174254B (es) 1994-05-02
PT94417A (pt) 1991-02-08
HRP920625A2 (en) 1994-08-31
SE8902237D0 (sv) 1989-06-20
DE69001461D1 (en) 1993-06-03
PL163988B1 (pl) 1994-06-30
JPH04506076A (ja) 1992-10-22
HU211024B (en) 1995-09-28
DK0404748T3 (da) 1993-08-23
IL94677A0 (en) 1991-04-15
FI915937A0 (fi) 1991-12-17
EP0404748B1 (en) 1993-04-28
CZ307190A3 (en) 1994-04-13
PL285701A1 (en) 1991-01-28
IE902161A1 (en) 1991-01-02
HUT59084A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
ES2051663T1 (es) Soporte para una protesis de valvula cardiaca.
DE69010336D1 (de) Pharmazeutische zusammensetzung zum abnehmen.
YU48528B (sh) Analozi 5-(1-hidroksi-2-piperidinopropil)-2-(1h,3h)-indolona
ES2051754T3 (es) Uso de derivados cetonicos en el tratamiento de la depresion.
ES2122015T3 (es) Uso de urodilatina en enfermedades pulmonares y bronquiales.
ES2054325T3 (es) Nuevos estereoisomeros.
SE9402880D0 (sv) New peptide derivatives
ES2171550T3 (es) Utilizacion de la 2,4-diaminopirimidina 3-oxido o de una de sus sales en el tratamiento de los desordenes de la maduracion y de la estructuracion del colageno.
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
WO1991016045A3 (en) Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
DE69129750T2 (de) Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung
ES2177769T3 (es) Derivado de aminotetralina para la terapia de trastornos cardiovascu lares.
BR9911237A (pt) Novo uso de um derivado de piridazinona
ES2042529T4 (es) Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.
ES2058780T3 (es) Uso de derivados de cinamamida en la fabricacion de una composicion farmaceutica para relajar el tono muscular.
ZA908267B (en) 5-(2-((2-amino-2-oxoethyl)(methyl)amino)ethyl)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepin-4-one derivatives,their preparation and their application in therapy
ATE128866T1 (de) Verwendung von naproxen als mydriatikum.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 404748

Country of ref document: ES